Drug shortage
Cyanocobalamin Spray · Endo Pharmaceuticals, Inc.
FDA drug shortage · To Be Discontinued · updated Jul 12, 2024
Key facts
| Generic name | Cyanocobalamin Spray |
|---|---|
| Proprietary name | Nascobal |
| Company | Endo Pharmaceuticals, Inc. |
| Presentation | Nascobal, Spray, 500 ug (NDC 49884-270-82) |
| Dosage form | Spray |
| Strength | 500 ug |
| Status | To Be Discontinued |
| Therapeutic category | Hematology |
| Package NDCs | 49884-270-82 |
| First posted | Jul 12, 2024 |
| Last updated | Jul 12, 2024 |
| Discontinued | Jul 12, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: